Stocks News

LAST PRICE
90.9900
TODAY'S CHANGE (%)
Trending Up3.3300 (3.7988%)

Bid / Lots
90.6500/ 1
Ask / Lots
91.4400/ 1
Open / Previous Close
87.4900 / 87.6600
Day Range
Low 87.4900
High 91.5800
52 Week Range
Low 70.7400
High 95.2600
Volume
749,023
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Apr 12, 2024
- DJ Haemonetics Is Maintained at Outperform by Barrington Research, from 10:53AM ET on Friday Apr 12, 2024 by Dow Jones
  10:53AM ET on Friday Apr 12, 2024 by Dow Jones
  Companies Mentioned: HAE
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/HAE/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 12, 2024 10:53 ET (14:53 GMT)
Apr 10, 2024
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024, from 4:59PM ET on Wednesday Apr 10, 2024 by PR Newswire
  4:59PM ET on Wednesday Apr 10, 2024 by PR Newswire
  Companies Mentioned: HAE
  Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter and fiscal year 2024 financial results at 6:00 am ET on Thursday, May 9, 2024. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on May 9, 2024.
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024, from 4:59PM ET on Wednesday Apr 10, 2024 by Dow Jones
  4:59PM ET on Wednesday Apr 10, 2024 by Dow Jones
  Companies Mentioned: HAE
  
  Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
  
  PR Newswire
  
  BOSTON, April 10, 2024
  
  BOSTON, April 10, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter and fiscal year 2024 financial results at 6:00 am ET on Thursday, May 9, 2024. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on May 9, 2024.
Apr 4, 2024
- Haemonetics Gets FDA Clearance for New TEG 6s Global Hemostasis-HN Cartridge, from 10:57AM ET on Thursday Apr 04, 2024 by MT Newswires
  10:57AM ET on Thursday Apr 04, 2024 by MT Newswires
  Companies Mentioned: HAE
  10:57 AM EDT, 04/04/2024 (MT Newswires) -- Haemonetics (HAE) said Thursday the US Food and Drug Administration has given 510(k) clearance to the new TEG 6s Global Hemostasis-HN assay cartridge. The cartridge extends its TEG 6s viscoelastic testing c...
- Haemonetics Receives FDA Clearance for New TEG(R) 6s Global Hemostasis - HN Cartridge, from 6:30AM ET on Thursday Apr 04, 2024 by PR Newswire
  6:30AM ET on Thursday Apr 04, 2024 by PR Newswire
  Companies Mentioned: HAE
  Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the TEG(R) 6s hemostasis analyzer system Global Hemostasis-HN assay cartridge. This new cartridge extends Haemonetics' TEG 6s viscoelastic testing capabilities to serve fully heparinized patients in adult cardiovascular surgeries/procedures and liver transplantation in both laboratory and point-of-care settings.

Apr 25, 2024
- LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident, from 4:03PM ET on Thursday Apr 25, 2024 by Business Wire
  4:03PM ET on Thursday Apr 25, 2024 by Business Wire
  Companies Mentioned: LIVN
Apr 18, 2024
- Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time, from 8:00AM ET on Thursday Apr 18, 2024 by GlobeNewswire
  8:00AM ET on Thursday Apr 18, 2024 by GlobeNewswire
  Companies Mentioned: LNTH
- --B. Riley Raises Price Target on Lantheus Holdings to $99 From $95, Keeps Buy Rating, from 7:57AM ET on Thursday Apr 18, 2024 by MT Newswires
  7:57AM ET on Thursday Apr 18, 2024 by MT Newswires
  Companies Mentioned: LNTH
Apr 16, 2024
- Glaukos Announces the Release of its 2023 Sustainability Report, from 4:05PM ET on Tuesday Apr 16, 2024 by Business Wire
  4:05PM ET on Tuesday Apr 16, 2024 by Business Wire
  Companies Mentioned: GKOS
Apr 11, 2024
- Mizuho Securities Adjusts Price Target on Glaukos to $100 From $85, Maintains Neutral Rating, from 9:50AM ET on Thursday Apr 11, 2024 by MT Newswires
  9:50AM ET on Thursday Apr 11, 2024 by MT Newswires
  Companies Mentioned: GKOS
- Glaukos Insider Sold Shares Worth $6,008,359, According to a Recent SEC Filing, from 9:20AM ET on Thursday Apr 11, 2024 by MT Newswires
  9:20AM ET on Thursday Apr 11, 2024 by MT Newswires
  Companies Mentioned: GKOS
Apr 10, 2024
- Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1, from 7:00AM ET on Wednesday Apr 10, 2024 by Business Wire
  7:00AM ET on Wednesday Apr 10, 2024 by Business Wire
  Companies Mentioned: GKOS
Apr 3, 2024
- Sector Update: Health Care Stocks Rise Wednesday Afternoon, from 1:54PM ET on Wednesday Apr 03, 2024 by MT Newswires
  1:54PM ET on Wednesday Apr 03, 2024 by MT Newswires
  Companies Mentioned: ABIO, ASXC, GKOS
- Glaukos Says iDose TR Assigned Permanent J-Code From US Centers for Medicare and Medicaid Services, from 11:12AM ET on Wednesday Apr 03, 2024 by MT Newswires
  11:12AM ET on Wednesday Apr 03, 2024 by MT Newswires
  Companies Mentioned: GKOS
- Glaukos Receives Permanent J-code for iDose(R) TR (travoprost intracameral implant), from 7:00AM ET on Wednesday Apr 03, 2024 by Business Wire
  7:00AM ET on Wednesday Apr 03, 2024 by Business Wire
  Companies Mentioned: GKOS

Haemonetics Corp
NYSE:HAEUnited States

Search Criteria

Apr 12, 2024

DJ Haemonetics Is Maintained at Outperform by Barrington Research, from 10:53AM ET on Friday Apr 12, 2024 by Dow Jones

Apr 10, 2024

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024, from 4:59PM ET on Wednesday Apr 10, 2024 by PR Newswire

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024, from 4:59PM ET on Wednesday Apr 10, 2024 by Dow Jones

Apr 4, 2024

Haemonetics Gets FDA Clearance for New TEG 6s Global Hemostasis-HN Cartridge, from 10:57AM ET on Thursday Apr 04, 2024 by MT Newswires

Haemonetics Receives FDA Clearance for New TEG(R) 6s Global Hemostasis - HN Cartridge, from 6:30AM ET on Thursday Apr 04, 2024 by PR Newswire

Peers Headlines

Apr 25, 2024

LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident, from 4:03PM ET on Thursday Apr 25, 2024 by Business Wire

Apr 18, 2024

Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time, from 8:00AM ET on Thursday Apr 18, 2024 by GlobeNewswire

--B. Riley Raises Price Target on Lantheus Holdings to $99 From $95, Keeps Buy Rating, from 7:57AM ET on Thursday Apr 18, 2024 by MT Newswires

Apr 16, 2024

Glaukos Announces the Release of its 2023 Sustainability Report, from 4:05PM ET on Tuesday Apr 16, 2024 by Business Wire

Apr 11, 2024

Mizuho Securities Adjusts Price Target on Glaukos to $100 From $85, Maintains Neutral Rating, from 9:50AM ET on Thursday Apr 11, 2024 by MT Newswires

Glaukos Insider Sold Shares Worth $6,008,359, According to a Recent SEC Filing, from 9:20AM ET on Thursday Apr 11, 2024 by MT Newswires

Apr 10, 2024

Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1, from 7:00AM ET on Wednesday Apr 10, 2024 by Business Wire

Apr 3, 2024

Sector Update: Health Care Stocks Rise Wednesday Afternoon, from 1:54PM ET on Wednesday Apr 03, 2024 by MT Newswires

Glaukos Says iDose TR Assigned Permanent J-Code From US Centers for Medicare and Medicaid Services, from 11:12AM ET on Wednesday Apr 03, 2024 by MT Newswires

Glaukos Receives Permanent J-code for iDose(R) TR (travoprost intracameral implant), from 7:00AM ET on Wednesday Apr 03, 2024 by Business Wire